Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Abstract Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at adv...

Full description

Saved in:
Bibliographic Details
Main Authors: L. E. Anselmino, M. V. Baglioni, F. Malizia, N. Cesatti Laluce, C. Borini Etichetti, V. L. Martínez Marignac, V. Rozados, O. G. Scharovsky, J. Girardini, M. J. Rico, M. Menacho Márquez
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/93cfc863cbba48eda474cd3a9008e6b4
Tags: Add Tag
No Tags, Be the first to tag this record!